Deutsche Bank initiated coverage on ACADIA Pharmaceuticals with a new price target
$ACAD
Biotechnology: Pharmaceutical Preparations
Health Care
Deutsche Bank initiated coverage of ACADIA Pharmaceuticals with a rating of Hold and set a new price target of $22.00